Thanks to a generous contribution from the LT Murray Family Foundation, Geneva is pleased to announce the first small grant competition for researchers at Joint Base Lewis-McChord! Geneva’s Scientific Advisory Board will be evaluating project proposals that are related to military medical research and are either pilot projects that enable the researcher to collect preliminary
Geneva’s Board of Directors recently elected Major General (Ret.) Frank Scoggins as its new Chair. Having served on Geneva’s Board since 2011, Major General Scoggins has demonstrated an active engagement in the success and growth of the organization’s mission, programmatic growth, and long-term financial sustainability. Major General Scoggins retired from the U.S. Air Force (USAF)
Geneva is pleased to announce the addition of Dr. Kenneth Bertram to the Board of Directors. Dr. Kenneth A. Bertram is the Clinical Product Development Officer for the Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC. In this position, he leads a team conducting early clinical trials using human stem cells to regulate the body’s
Geneva’s first 2019 Join the Conversation event on 5 February featuring Geneva researcher and employee Dr. Brad Isaacson was a resounding success. After a welcoming address and the honoring of outgoing Board Chair Michael Hansch from Founder & Chief Strategy Officer Jane Taylor, Board of Directors Chair Major General (Ret.) Frank Scoggins and President &
Thank you Senior Research Scientist Joel Gaston, for your outstanding service and dedication to Geneva’s core values and mission! The photo above is Geneva Program Manager Linzie Wagner (L) with Q4 2018 Wave the Flag recipient Joel Gaston (R). An excerpt from his nomination states: “Joel Gaston was hired on to the 4D Bio3 team as
IDENTIFYING SUBGROUPS OF TINNITUS USING NOVEL RESTING STATE FMRI BIOMARKERS AND CLUSTER EXPLORATION COL (RET.) CARLOS ESQUIVEL, MD, CHIEF MEDICAL OFFICER, DEPARTMENT OF DEFENSE HEARING CENTER OF EXCELLENCE Wilford Hall Ambulatory Surgical Center In collaboration with the University of Illinois at Urbana-Champaign (UIUC), Dr. Esquivel’s recent work at Wilford Hall Ambulatory Surgical Center involves the
ROLE OF IV KETAMINE ON FEAR MEMORY AND BRAIN ACTIVATION IN MALE & FEMALE RATS CDR KENNETT RADFORD, PHD, CRNA Uniformed Services University Ketamine, a multimodal dissociative anesthetic, is the most common battlefield analgesic administered to combat wounded service members, but little is known regarding potential long-term psychological impacts. A limited number of investigations have
EFFECTIVENESS OF A VESTIBULAR OCULAR MOTOR SCREENING (VOMS) TOOL FOR IDENTIFYING mTBI AND TRACKING RECOVERY IN MILITARY PERSONNEL ANTHONY P. KONTOS, PHD, UNIVERSITY OF PITTSBURGH (PRIME); MAJ KATRINA MONTI, MPAS, JOINT BASE LEWIS MCCHORD (GENEVA) Joint Base Lewis-McChord (JBLM) Vestibular impairment and ocular motor dysfunction are prevalent among military personnel exposed to blast-related mild traumatic
TRANSLATIONAL PORTFOLIO PROGRAM ENCOMPASSING CGMP MANUFACTURING AND CLINICAL DEVELOPMENT OF DNA VACCINE CANDIDATES AGAINST BOTH LASSA VIRUS AND MERS CORONAVIRUS KATHLEEN CASHMAN, PHD U.S. Army Medical Research Institute of Infectious Diseases The Lassa virus (LASV), endemic to West Africa, infects 300,000+ people annually. Individuals hospitalized and diagnosed with the infection average a mortality rate of
Geneva is proud to highlight our activities and accomplishments over the past year as we continue to advance exceptional medical research within the U.S. military. In 2018, Geneva supported over 230 researchers and over 460 research programs in areas including oncology, infectious diseases, orthopedics, gastroenterology, and hepatology. Our organization is forever grateful for our sponsors